Sale

Digital Therapeutics Market

Global Digital Therapeutics Market Size, Share, Analysis, Trends, Forecast: By Product Type: Software, Devices; By Applications: Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Diseases, CNS Diseases, Others; By End User: Patients, Healthcare Providers, Healthcare Consumers, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Digital Therapeutics Market Outlook

The global digital therapeutic market size attained a value of USD 5.1 billion in 2023. The market is anticipated to grow at a CAGR of 25.3 % during the forecast period of 2024-2032 to attain a value of USD 38.8 billion by 2032. The growth of the market is driven by the increased prevalence of diabetes.

 

Global Digital Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Prevalence of Diabetes to Augment the Digital Therapeutics Industry Growth

Based on application, the diabetes segment is the major revenue generator due to the increasing incidence of diabetes, and this trend is projected to continue over the forecast period as well. Moreover, diabetes has the highest comparative incidence rates in North America, the Middle East, and North Africa, which pushes up the demand for digital therapeutics among diabetic patients in these regions. The digital therapeutics industry in North America is fuelled by factors, such as the entry of new start-ups, rising investments in digital therapeutics, changes in the reimbursement system for digital therapeutics, and government initiatives to promote technological breakthroughs.

 

Digital Therapeutics: Market Segmentation

Digital therapeutics, a category of digital health, is referred to as evidence-based therapeutic interventions powered by high-quality software programmes to prevent, manage, or treat a medical disorder or disease.

 

Global Digital Therapeutics Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By application, the market is divided into:

  • Diabetes
  • Obesity
  • Cardiovascular Diseases (CVD)
  • Central Nervous System (CNS) Disease
  • Respiratory Diseases
  • Smoking Cessation
  • Others

Based on end use, the industry can be categorised into:

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Digital Therapeutics Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Focus on Preventive Healthcare to Bolster the Growth of the Digital Therapeutics Industry

The rising prevalence of chronic diseases, the need to reduce healthcare costs, a growing focus on preventive healthcare, and increasing investments in digital therapeutics are all driving the market growth. Chronic diseases' high prevalence and the incidence rate is a serious problem for healthcare systems all over the world. Patients with chronic diseases provide a considerable barrier in terms of therapy, since psychosomatic or biopsychic variables frequently affect these patients. Many chronic diseases and conditions progress over time, and their prevalence rises as people get older. As a result, chronic diseases are expected to rise even more throughout the forecast period as the global geriatric population grows. This is expected to provide considerable growth opportunities for the digital therapeutics industry.

 

Key Industry Players in the Global Digital Therapeutics Market

The report gives a detailed analysis of the following key players in the global digital therapeutics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Omada Health, Inc.
  • WellDoc, Inc.
  • Livongo Health, Inc.
  • Mango Health, Inc.
  • Canary Health, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Applications
  • End User
  • Region
Breakup by Product Type
  • Software
  • Devices
Breakup by Applications
  • Diabetes
  • Obesity
  • CVD
  • Respiratory Diseases
  • Smoking Diseases
  • CNS Diseases
  • Others
Breakup by End User
  • Patients
  • Healthcare Providers
  • Healthcare Consumers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Omada Health, Inc.
  • ResMed
  • Pear Therapeutics, Inc.
  • Solera Network
  • Akili Interactive Labs, Inc.
  • Better Therapeutics, LLC
  • Biofourmis
  • Click Therapeutics, Inc.
  • Naturalcycles Nordic AB
  • NuvoAir AB
  • Welldoc’s Bluestar
  • Happify, Inc.
  • Limbix Health, Inc.
  • Voluntis
  • Xealth
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope
    1.4    Research Methodology
2    Executive Summary
3    Global Digital Therapeutic Market Overview 

    3.1    Global Digital Therapeutic Market Historical Value (2017-2023) 
    3.2    Global Digital Therapeutic Market Forecast Value (2024-2032)
4    Global Digital Therapeutic Market Landscape
    4.1    Global Digital Therapeutic Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Digital Therapeutic Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by End User
        4.2.3    Analysis by Applications
5    Global Digital Therapeutic Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators``
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Digital Therapeutic Market Segmentation
    6.1    Global Digital Therapeutic Market, by Product Type
        6.1.1    Software 
        6.1.2    Devices
    6.2    Global Digital Therapeutic Market, by Applications
        6.2.1    Market Overview
        6.2.2    Diabetes 
        6.2.3    Obesity
        6.2.4    CVD
        6.2.5    Respiratory Diseases
        6.2.6    Smoking Diseases
        6.2.7    CNS Diseases
        6.2.8    Others
    6.3    Global Digital Therapeutic Market, by End User
        6.3.1    Market Overview
        6.3.2    Patients
        6.3.3    Healthcare Providers
        6.3.4    Healthcare Consumers
        6.3.5    Others
    6.4    Global Digital Therapeutic Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Digital Therapeutic Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Digital Therapeutic Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Digital Therapeutic Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Digital Therapeutic Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Digital Therapeutic Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Omada Health, Inc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    ResMed
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Pear Therapeutics, Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Solera Network
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Akili Interactive Labs, Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Better Therapeutics, LLC
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Biofourmis
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Click Therapeutics, Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Naturalcycles Nordic AB
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    NuvoAir AB
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Welldoc’s Bluestar
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    Happify, Inc.
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Limbix Health, Inc.
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    Voluntis
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    Xealth
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
18    Global Digital Therapeutics Market- Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global digital therapeutics market was valued at USD 5.1 billion in 2023.

The market is expected to grow at a CAGR of 25.3% from 2024 to 2032 to reach a value of USD 38.8 billion by 2032.

The major drivers of the market include the rising prevalence of chronic diseases, the need to reduce healthcare costs, a growing focus on preventive healthcare, and increasing investments in digital therapeutics.

The market is expected to be positively influenced by the technological advancements going on in the industry.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different applications of digital therapeutics are diabetes, obesity, cardiovascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, and smoking cessation, among others.

The various end uses of digital therapeutics are patients, providers, payers, and employers, among others.

The major players in the industry are Omada Health Inc., WellDoc Inc., Livongo Health Inc., Mango Health Inc., and Canary Health Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 7999     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 9999     $5999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER